Topic

Carolina Ahrendt is an associate principal consultant, program leader, for Halloran Consulting Group.

Pam Wilson is a lead consultant, program manager, for Halloran Consulting Group.

Julia Libunao is a lead consultant, strategy and program leadership, for Halloran Consulting Group.

Articles

Delivering value with enterprise program management.

Why Program Management is the Key to Success for Life Science Companies 

SVP, Global Strategy, Global Marketing, and NA Sales, Ashfield Engage, an Inizio Engage company

What the c-suite should consider in today’s marketplace.

Key Factors Attributing to a Successful  Product Launch

Rohit Gupta is vice president of analytics strategy and transformation at 

As they are forced to do more with less, pharma commercial leaders should rethink their incentive programs to ensure their sales teams remain strong drivers of growth.

Sales-Rep Compensation: Adding Long-Term Incentives to Mix 

 and can be reached at mhollan@mjhlifesciences.com.

Pharma companies are teaming with academic institutions earlier in the R&D process.

Co-creating New Innovations

Lisa Henderson is the group editorial director of 

 and can be reached at lhenderson@mjhlifesciences.com.

Interpreting what the Inflation Reduction Act could mean for biopharma.

The Potential Impact of the IRA

 and can be reached at mrivers@mjhlifesciences.com.

How technology will play a big role in advancing pharma approaches in patient support.

Patient Hubs Continue Growth

 and can be reached at fpollaro@mjhlifesciences.com.

As new channels enter healthcare conversation mix, engagement strategies are changing.

Social Media’s Complex Climb

 and can be reached at astudna@mjhlifesciences.com. 

An evolving job market has forced life sciences companies to respond.

Industry Workforce Seeks Clarity

The steps companies can take now to better protect themselves and their data.

Cybersecurity Threats & Pharma

Baker spoke on topics ranging from pricing, access, the war for talent, and other key areas that are impacting pharma companies.

Industry Trends